Furthermore, the Th17 response in COVID-19 patients [100] instigates pro-inflammatory cytokine IL-17, which employs monocytes and neutrophils to pulmonary circulation and initiates a surge of surplus cytokines such as IL-1β and IL-6 [100]. The gene discussed is IL1B; the disease is COVID-19.